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Title: Exercise for Breast Cancer Survivors: Bridging the Gap Between Evidence and 
Practice 
Abstract  
Evidence supporting the benefits of exercise following the diagnosis of breast cancer 
is overwhelming and compelling. Exercise reduces the severity and number of 
treatment-related side effects, optimizes quality of life during and following treatment 
and may optimize survival. Yet, exercise does not uniformly form part of the standards 
of care provided to women following a breast cancer diagnosis. This commentary 
summarizes the evidence in support of exercise as a form of adjuvant treatment and 
identifies and discusses potential issues preventing the formal integration of exercise 
into breast cancer care. Proposed within the commentary is a model of breast cancer 
care that incorporates exercise prescription as a key component but also integrates 
the need for surveillance and management for common breast cancer treatment-
related morbidities, as well as education.  While future research evaluating the 
potential cost-savings through implementation of such a model is required, a 
committed, collaborative approach by clinicians, allied health professionals and 
researchers will be instrumental in bridging the gap between research and practice. 
 






Evidence supporting the benefits of exercise following the diagnosis of breast 
cancer is overwhelming and compelling. Summarized in multiple meta-analyses and 
systematic reviews, the results from over 68 randomized, controlled trials involving 
exercise interventions in women with breast cancer have clearly demonstrated 
attenuation of treatment-related morbidity and multiple physical and psychosocial 
health benefits during and following treatment, all of which optimize quality of 
survival[1-2]. Specifically, exercise interventions during and/or following breast cancer 
treatment can prevent decline and/or improve cardio-respiratory fitness, body 
composition (i.e., muscle mass and bone health), immune function, strength and 
flexibility, cognition, body image, self-esteem and mood, chemotherapy completion 
rates and allow for better adjustment to illness[3].  Exercise interventions have also 
been shown to reduce hospitalization duration, stress, depression, anxiety and the 
number and severity of treatment side effects, including nausea, lymphedema, fatigue 
and pain[3].  
In addition, evidence from multiple cohort studies, summarized in a recent 
meta-analysis, demonstrates that post-diagnosis physical activity may be associated 
with 41% reduced all-cause mortality, 34% fewer breast cancer deaths and 24% 
reduced risk of disease recurrence, with the effect independent of other prognostic 
factors[4]. Exercise also reduces risk of other comorbidities for which breast cancer 
survivors are at increased risk, including osteoporosis, diabetes, and heart disease[5]. 
This is especially important since breast cancer survivors are at least as likely to die of 
heart disease as of breast cancer[6-7]. Importantly, the benefits accrued through 
participation in regular exercise extend well beyond the woman, influencing her role 
within the family, workplace and broader society.  
The global Exercise is Medicine® campaign (http://exerciseismedicine.org/)  
highlights exercise as an important mechanism for the prevention and treatment of 
chronic disease.  Evidence in support of exercise as a form of adjuvant breast cancer 
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treatment continues to mount.  Importantly, all women diagnosed with breast cancer, 
irrespective of age, race, risk of morbidity, and stage of disease, can benefit from 
exercise during and following treatment[3]. Further, risk of adverse events and poorer 
quality of life may be higher in those who do not exercise[8-9]. This is in contrast to 
other forms of adjuvant breast cancer treatment, such as chemotherapy, whereby 
survival benefits accrued are only available to women for whom this form of treatment 
is indicated (40-50% of breast cancer patients)[10], and are often accompanied by a 
myriad of side effects, some of which may persist for months or years[11]. This 
comparison is not being made to suggest exercise as a potential alternative to 
chemotherapy, but to help reinforce the evidence demonstrating the usefulness of 
exercise as an adjunct to breast cancer treatment, and one that is complementary to 
current standards of care.  Yet, exercise is not a uniform component of breast cancer 
survivorship care.  Potential issues influencing the integration of exercise as a form of 
adjuvant breast cancer treatment are proposed below:  
Capacity for exercise behavior change: 
Approximately 85% of breast cancer survivors report being less physically 
active than recommended levels (150 minutes of moderate-intensity activity per week) 
[12] and women are more likely to reduce activity levels during and following 
treatment[13]. Not only do these women likely lack the knowledge and skills to 
become or stay sufficiently active, breast cancer treatment may result in physiologic 
and/or psychosocial changes that deepen the need for general and breast cancer-
specific exercise know-how advice and support. For example, at least one in two 
women report upper-body morbidity and 40% experience upper-body function 
declines following breast cancer[14]. Common adverse treatment sequelae, such as 
fatigue, anxiety and depression, also represent common exercise barriers, but ones 
that can be overcome through the health promoting effects of exercise[1-2, 15]. 
Further, even when self-reported pre-diagnosis physical activity levels are maintained, 
multiple cohort studies have shown that a significant minority of breast cancer 
4 
 
survivors sustain long term deficits in functional status compared to women who have 
not had breast cancer[16-18].   
A diagnosis of breast cancer has been considered a “teachable moment” for 
positive changes in exercise behavior[19].  Also, results from exercise intervention 
studies demonstrate high adherence rates (70-90%) to the exercise intervention[20], 
indicating that participation in exercise is feasible. Taken together, these findings 
suggest there is a need and capacity for change. 
Optimal timing and dose of exercise 
Exercise interventions have been initiated within six-weeks post-surgery, 
during adjuvant therapy and up to many years following treatment[1]. Exercise 
interventions during adjuvant therapy have been associated with prevention in 
declines in function and fewer and less severe treatment-related side effects[1, 21]. 
Exercise post-treatment assists to mitigate symptoms and to optimize recovery[1, 21]. 
Ultimately, when exercise is prescribed progressively and is individualized to 
accommodate each woman’s function and symptoms, exercise can be commenced at 
any time following a breast cancer diagnosis[3].  
While the dose of exercise evaluated in the many randomized, controlled trials 
involving women with breast cancer varies significantly, findings from this work have 
been used to derive exercise prescription guidelines[3, 21-22].  As a minimum, 
benefits have been observed in exercise interventions involving aerobic- and/or 
resistance-based exercise performed at least three sessions per week, for at least 30 
minutes per session, at moderate intensity[3, 21].  When survival is the outcome of 
interest, there is some evidence derived from cohort studies to suggest a dose-
response relationship exists [3], whereby more exercise is better than less, but 
possibly only up to levels meeting national recommendations (150 minutes of 
moderate-intensity activity per week). While the current evidence does not allow 
inferences to be made about the lower- and upper-thresholds of exercise required to 
achieve benefits, individualizing starting exercise levels and pace for progression is 
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considered a crucial component of exercise prescription for women with breast 
cancer[3]. Exercise is like any other form of treatment – its efficacy is dependent on 
appropriate prescription of type, dosing, and timing that is specific to each woman. 
Safety of exercise: 
Exercise in cancer survivors is considered to be safe. Among the studies that 
have reported adverse effects, they have been rare and mild in nature (e.g., plantar 
fasciitis from walking and other musculoskeletal injuries) [20-21]. However, it is 
important to remember that a response bias exists in exercise intervention trials, with 
participants likely to be younger, healthier and have a history of exercise participation, 
compared with the wider breast cancer cohort. It is therefore important to avoid 
complacency with exercise prescription, and also highlights the need for exercise to 
be prescribed by trained health professionals, such as exercise 
physiologists/kinesiologists and undertaken in supervised environments, until exercise 
safety has been established within clinical settings (beyond research settings). 
Potential for initiation or exacerbation of treatment-related concerns: 
Fatigue and lymphedema merit special attention in this regard, as they 
represent symptoms that have previously been treated with rest. However, evidence 
demonstrates that it is too much sedentary behavior rather than participation in a 
progressive exercise program that is likely to exacerbate or contribute to the 
development of these conditions[9, 23]. Also, evidence from supervised exercise 
intervention trials demonstrate that at worst, exercise has no effect on existing fatigue 
and lymphedema, but may reduce symptom severity and exacerbation[15, 24-25]. 
However, again, this evidence is derived from supervised programs under the 
direction of trained professionals during times when these symptoms are already 
present or were most likely to develop.   
Potential cost of integrating exercise into breast cancer care:   
This is a more difficult issue to deal with, as the cost-effectiveness of exercise 
as a form of adjuvant breast cancer treatment is yet to be established and there is a 
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real need for more research in this area.  Further, who pays will at least be partly 
dependent on the national health system in place for any given country. Many 
European countries have inpatient and/or outpatient cancer rehabilitation broadly 
available to cancer patients[26]. The extent to which this programming includes 
exercise is not clear. Given the concerns with costs, it is pertinent to highlight that 
exercise treatment has the potential to lead to significant short- and longer-term cost-
savings, by way of preventing disability, reducing symptom severity or alleviating 
common treatment-related sequelae such as fatigue, lymphedema and pain. Further, 
these potential cost-savings will likely extend beyond the oncology treatment setting 
by influencing a woman’s ability to function effectively within her home, work 
environment and community. 
Proposed model of breast cancer collaborative care that incorporates exercise: 
Figure 1 represents a proposed breast cancer rehabilitation model, which 
incorporates exercise prescription as a core component but in doing so, recognizes 
the importance of education, evaluation and prospective surveillance of treatment-
associated morbidity. This model, draws on experiences learned in the cardiac 
rehabilitation setting[27] but integrates recommendations in a way that is relevant to 
the breast cancer setting.  The model proposes that all women, irrespective of age, 
presence of comorbidities, stage of treatment and presence of treatment-related 
sequelae, should be referred to breast cancer rehabilitation, which includes exercise 
prescription, although under certain circumstances, formal entry may be delayed until 
assessment and appropriate management of specific disease or treatment-related 
concerns can occur.   
The model relies on triaging breast cancer patients for referral to appropriate 
allied health professionals according to need AND referral to breast cancer 
rehabilitation.  The appropriate medical professional to address this ‘triage’ step might 
be the breast care nurse as they are now established internationally and play a key 
role in supporting women in coping with the impact of the disease and its 
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treatment[28]. However, the specifics of this process will likely be dependent on the 
strengths and staffing of a particular setting. 
Entry into breast cancer rehabilitation involves commencement of education, 
which over time will cover issues including recognition and risk-reduction strategies of 
treatment-related morbidities and uptake or maintenance of healthy lifestyle 
behaviors. Evaluation of baseline health and fitness and commencement of 
prospective surveillance of relevant morbidities should occur. Using information 
derived from the evaluation component, and building on education strategies, women 
should formally receive an exercise prescription. All three components of the model 
are integrated, informing each other, and in doing so will help to ensure that individual 
patient circumstances such as, accommodations needed for work, family, and societal 
roles, as well as changing symptoms during active treatment, are considered in the 
provision of care. For example, while exercise prescription will work to minimize risk of 
developing treatment-related concerns, integration of the model into breast cancer 
care will also enable early identification and management of treatment-related 
morbidities should they present.  If morbidities do present, patients stay within the 
model but are also referred for more specific evaluation and treatment. 
In the early phase of the proposed breast cancer rehabilitation model level of 
education and evaluation is high, with more frequent surveillance of morbidities. 
Exercise is undertaken in supervised settings, under the direction of qualified health 
professionals, with exercise goals being short-term in nature (focused on weekly 
exercise targets), with flexibility to accommodate change in presence and/or severity 
of treatment-related morbidities. However, over time provision of information is 
reduced, prospective surveillance of morbidities declines and exercise is undertaken 
in community-based settings, with or without formal prescription from a health 
professional. The later phase of breast cancer rehabilitation represents the time at 
which women have the capacity, skills and know-how to independently monitor 
presence and change in persistent treatment-related symptoms, and to know how to 
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respond when adverse changes occur. It also represents the time when safety of 
participating in regular exercise, supervised or unsupervised, has been established, 
and exercise goals begin to have a longer-term focus (e.g., sustaining health behavior 
change in exercise habits). While the later phase of breast cancer rehabilitation may 
be well handled by broadly disseminated programs like those administered by breast 
cancer support groups or YMCA’s initiatives, it should not be dependent on the 
availability of such programs.  
Movement within the components of education, surveillance and exercise 
prescription may occur at different pace.  For example, a woman who has a history of 
exercising regularly, may require comparatively less exercise prescription support and 
advice following her breast cancer diagnosis but may require high levels of education 
relating to understanding common treatment-related concerns and ways to identify 
them.  Also some women may systematically progress through breast cancer 
rehabilitation towards low levels of education, surveillance and exercise prescription 
support and advice (e.g., a woman who has had a lumpectomy with no adjuvant 
therapy and who has not experienced any treatment-related side effects).  Others may 
find they progress and regress along the breast cancer rehabilitation continuum (e.g., 
a woman who develops lymphedema at 6-months post-diagnosis may move back to 
more highly supervised, medically-prescribed exercise for a period, despite being an 
independent exercise in a community-based setting prior to her lymphedema 
diagnosis). Nonetheless, it is anticipated that the vast majority of women will have 
entered the later phases of breast cancer rehabilitation, categorized by low levels of 
education, less frequent symptom evaluation and minimal (to no) levels of supervised 
exercise advice and support by 12 months post-diagnosis.  The flexible nature of the 
proposed model seeks to optimize efficiency of the model and minimize associated 
costs. 
The model acknowledges that for many treating centers, in particular centers 
that sit within well-resourced health systems, there already exists a breast cancer care 
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model that integrates a multidisciplinary team in the management of women with 
breast cancer. However, the current efficiencies of any given system vary widely. 
Even when a model that integrates a multidisciplinary team exists, it is plausible that 
at times, if not frequently, it operates on a ‘squeaky wheel’ approach.  That is, those of 
higher socioeconomic status who have the capacity to follow-up change in treatment-
related symptoms will be more likely referred, evaluated and treated, compared with 
those of poorer socioeconomic status[29]. This is a system which contributes to the 
health disparities commonly observed across socioeconomic status and ethnicity for 
breast cancer-related morbidities and mortality[30-31].  
The model proposed here seeks to utilize, formalize and expand on existing 
infrastructure, health professionals and resources and to do so in a way that is 
advantageous to all women with breast cancer. Specifically, the model will not only 
enable early integration of exercise as a form of adjuvant treatment, but will aid 
prevention, early detection and management of treatment-related symptoms[32]. We 
acknowledge that this is not the first time a breast cancer rehabilitation model has 
been proposed; nor are we the first to advocate for the integration of exercise into 
survivorship care for women with breast cancer. It may also be perceived as an 
idealist model and one that would certainly be implemented if there exists the 
infrastructure and resources to support such a model. That time seems to be 
approaching.  As indicated earlier, guidelines for exercise prescription for women with 
breast cancer already exist[3, 21-22], as do tertiary-trained health professionals who 
have the skills and experience in prescribing such treatment. Further, a number of 
programs have been developed and disseminated at the community level that could 
be utilized as part of the later phase of breast cancer rehabilitation, such as the YWCA 
Encore program in the U.S.A. and Australia, the LIVESTRONG at the YMCA program 
in the USA, or the Swedish physical activity referral scheme[33]. Nonetheless, there 
will likely be some ‘tipping point’ that will lead to breast cancer rehabilitative and 
exercise programming becoming part of ‘standard of care’. With cardiac rehabilitation, 
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there was never a single definitive randomized trial that established that exercise 
reduced recurrence or cardiac mortality, though a meta-analysis finally established 
this causal link in 1988[34]. There was, however, evidence that exercise rehabilitation 
could get patients out of the hospital sooner and assist patients in returning to their 
roles within family and society[35]. For breast cancer rehabilitation, there is not yet a 
randomized controlled trial of the effects of exercise on recurrence or cost savings, 
which would improve insurance reimbursement of these programs. However, if the 
cardiac rehabilitation story teaches us anything, it may be that we need not wait for 
those results to push toward a model of breast cancer rehabilitation that incorporates 
exercise prescription. Whatever the tipping point may be, it is clear that a change in 
practice will require collaborative efforts between those involved with the management 
of women with breast cancer, with a particular emphasis on active support for 
integrating exercise as a form of adjuvant therapy from clinicians[36-37]. Together, 
researchers, clinicians and allied health professionals can help bridge the gap 
between what is fast becoming public knowledge about the important role of exercise 
for a variety of health outcomes following a breast cancer diagnosis and the provision 
of high quality rehabilitative exercise programming to all breast cancer patients as 
standard care.  
 
Figure 1. Proposed breast cancer rehabilitation model which integrates surveillance, prevention 
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